INTERNATIONAL PATENT: KOLM THERAPEUTICS INC. FILES APPLICATION FOR "CBP/P300 HETEROBIFUNCTIONAL CONDITIONAL INHIBITORS"

GENEVA, Oct. 28 -- KOLM THERAPEUTICS INC. (4 Research Dr.Woodbridge, Connecticut 06525) filed a patent application (PCT/US2025/025023) for "CBP/P300 HETEROBIFUNCTIONAL CONDITIONAL INHIBITORS" on Apr 16, 2025. With publication no. WO/2025/221930, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NEKLESA, Taavi (4 Research Dr.Woodbridge, Connecticut 06525), VIGIL, Dominico (4 Research Dr.Woodbridge, Connecticut 06525), BOSANAC, Todd (4 Research Dr.Woodbridge, Connecticut 06525), HIRD, Alexander W. (4 Research Dr.Woodbridge, C...